WO2025219948 - CRYSTALLINE FORMS OF GOVORESTAT
National phase entry is expected:
Publication Number
WO/2025/219948
Publication Date
23.10.2025
International Application No.
PCT/IB2025/054075
International Filing Date
17.04.2025
Title **
[English]
CRYSTALLINE FORMS OF GOVORESTAT
[French]
FORMES CRISTALLINES DE GOVORESTAT
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SINGH, Amit
SINGH, Drishti
Priority Data
202411030891
17.04.2024
IN
202411046807
18.06.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2110 | |
| EPO | Filing, Examination, Granting | 8643 | |
| Japan | Filing, Examination, Granting | 2192 | |
| South Korea | Filing, Examination, Granting | 2150 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
22,835
Contact Us
Abstract[English]
The application relates to crystalline polymorphs of Govorestat, processes for preparation thereof, and pharmaceutical compositions thereof.[French]
La demande concerne des polymorphes cristallins de Govorestat, leurs procédés de préparation et des compositions pharmaceutiques associées.